NO20062450L - Analgesiske suspensjoner med kontrollert frigivelse - Google Patents
Analgesiske suspensjoner med kontrollert frigivelseInfo
- Publication number
- NO20062450L NO20062450L NO20062450A NO20062450A NO20062450L NO 20062450 L NO20062450 L NO 20062450L NO 20062450 A NO20062450 A NO 20062450A NO 20062450 A NO20062450 A NO 20062450A NO 20062450 L NO20062450 L NO 20062450L
- Authority
- NO
- Norway
- Prior art keywords
- controlled release
- release analgesic
- suspensions
- analgesic suspensions
- acetaminophen
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 239000000725 suspension Substances 0.000 title 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- 239000006194 liquid suspension Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/697,546 US20050095299A1 (en) | 2003-10-30 | 2003-10-30 | Controlled release analgesic suspensions |
| PCT/US2004/034709 WO2005044230A2 (en) | 2003-10-30 | 2004-10-21 | Controlled release analgesic suspensions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062450L true NO20062450L (no) | 2006-05-30 |
Family
ID=34550387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062450A NO20062450L (no) | 2003-10-30 | 2006-05-30 | Analgesiske suspensjoner med kontrollert frigivelse |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050095299A1 (pt) |
| EP (1) | EP1694297B1 (pt) |
| JP (1) | JP2007509937A (pt) |
| KR (1) | KR20060096492A (pt) |
| CN (1) | CN1874754A (pt) |
| BR (1) | BRPI0415628A (pt) |
| CA (1) | CA2543497C (pt) |
| ES (1) | ES2408308T3 (pt) |
| NO (1) | NO20062450L (pt) |
| RU (1) | RU2006118696A (pt) |
| WO (1) | WO2005044230A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060093631A1 (en) * | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
| CA2586288A1 (en) * | 2004-12-06 | 2006-06-15 | Janssen Pharmaceutica Nv | Oral suspension comprising meloxicam |
| US20090022798A1 (en) * | 2007-07-20 | 2009-01-22 | Abbott Gmbh & Co. Kg | Formulations of nonopioid and confined opioid analgesics |
| US20090317355A1 (en) * | 2006-01-21 | 2009-12-24 | Abbott Gmbh & Co. Kg, | Abuse resistant melt extruded formulation having reduced alcohol interaction |
| US20100172989A1 (en) * | 2006-01-21 | 2010-07-08 | Abbott Laboratories | Abuse resistant melt extruded formulation having reduced alcohol interaction |
| US20080057122A1 (en) * | 2006-08-31 | 2008-03-06 | Aaipharma Inc. | Acetaminophen pharmaceutical compositions |
| US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
| RU2011133020A (ru) * | 2009-01-09 | 2013-02-20 | Панацеа Биотек Лтд. | Фармацевтические суспензии двойного высвобождения |
| US8529914B2 (en) | 2010-06-28 | 2013-09-10 | Richard C. Fuisz | Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
| WO2012100295A1 (en) * | 2011-01-27 | 2012-08-02 | Mayne Pharma International Pty Ltd | Extended release acetaminophen liquid pharmaceutical compositions |
| KR101561345B1 (ko) * | 2013-10-17 | 2015-10-16 | 대원제약주식회사 | 제어방출되는 프로피온산 계열의 약제학적 조성물 |
| FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
| CN108926530A (zh) * | 2018-08-17 | 2018-12-04 | 江苏科瑞达药业有限公司 | 一种具有高效混悬作用的对乙酰氨基酚液体制剂 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485719A (en) * | 1967-10-13 | 1969-12-23 | Us Agriculture | Continuous process for producing xanthomonas heteropolysaccharide |
| GB1497044A (en) * | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
| US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
| GB8317696D0 (en) * | 1983-06-29 | 1983-08-03 | Shell Int Research | Preparing xanthomonas heteroplysaccharide |
| US4762709A (en) * | 1983-09-16 | 1988-08-09 | Pennwalt Corporation | Liquid prolonged release pharmaceutical formulations containing ionic constituents |
| US4847077A (en) * | 1984-07-18 | 1989-07-11 | Pennwalt Corporation | Controlled release pharmaceutical preparations |
| IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4873231A (en) * | 1986-04-08 | 1989-10-10 | Smith Walton J | Decreasing the toxicity of an ibuprofen salt |
| JPS6327424A (ja) * | 1986-07-17 | 1988-02-05 | Shionogi & Co Ltd | 徐放性製剤およびその製造法 |
| US4859461A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Coatable ion exchange resins |
| US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
| US4861797A (en) * | 1987-10-15 | 1989-08-29 | Oratech Pharmaceutical Development Corporation | Liquid ibuprofen compositions and methods of making them |
| GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
| DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
| US4906478A (en) * | 1988-12-12 | 1990-03-06 | Valentine Enterprises, Inc. | Simethicone/calcium silicate composition |
| US4975465A (en) * | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| NZ234143A (en) * | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
| US5527545A (en) * | 1989-09-18 | 1996-06-18 | Recordati S.A. Chemical And Pharmaceutical Company | Liquid-suspension controlled-release pharmaceutical composition |
| US5275822A (en) * | 1989-10-19 | 1994-01-04 | Valentine Enterprises, Inc. | Defoaming composition |
| IE66933B1 (en) * | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
| CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
| US5183829A (en) * | 1991-09-27 | 1993-02-02 | Applied Analytical Industries, Inc. | Oral liquid compositions of non-steroidal anti-inflammatory drugs |
| US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
| FI941777A7 (fi) * | 1993-04-16 | 1994-10-17 | Mcneil Ppc Inc | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi |
| IT1264855B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici |
| US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
| US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
| EP0946145B1 (en) * | 1996-12-20 | 2008-09-03 | McNeil-PPC, Inc. | Antitussive drugs delivered by ion exchange resins |
| US6103260A (en) * | 1997-07-17 | 2000-08-15 | Mcneil-Ppc, Inc. | Simethicone/anhydrous calcium phosphate compositions |
| US5885616A (en) * | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
| CN1277550A (zh) * | 1997-09-11 | 2000-12-20 | 尼科梅德丹麦有限公司 | 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物 |
| US6197347B1 (en) * | 1998-06-29 | 2001-03-06 | Andrx Pharmaceuticals, Inc. | Oral dosage for the controlled release of analgesic |
| US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| US6126967A (en) * | 1998-09-03 | 2000-10-03 | Ascent Pediatrics | Extended release acetaminophen particles |
| US6254891B1 (en) * | 1998-09-03 | 2001-07-03 | Ascent Pediatrics, Inc. | Extended release acetaminophen |
| IN191239B (pt) * | 1999-06-11 | 2003-10-11 | Ranbaxy Lab Ltd | |
| ES2258988T3 (es) * | 1999-12-22 | 2006-09-16 | Pharmacia Corporation | Composiciones de liberacion dual de un inhibidor de la ciclooxigenasa-2. |
| GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
| US7223421B2 (en) * | 2000-06-30 | 2007-05-29 | Mcneil-Ppc, Inc. | Teste masked pharmaceutical particles |
| AU2003271024A1 (en) * | 2002-09-21 | 2004-04-08 | Jin Wang | Sustained release compound of acetamidophenol and tramadol |
-
2003
- 2003-10-30 US US10/697,546 patent/US20050095299A1/en not_active Abandoned
-
2004
- 2004-10-21 EP EP04795819.4A patent/EP1694297B1/en not_active Expired - Lifetime
- 2004-10-21 ES ES04795819T patent/ES2408308T3/es not_active Expired - Lifetime
- 2004-10-21 WO PCT/US2004/034709 patent/WO2005044230A2/en not_active Ceased
- 2004-10-21 CA CA2543497A patent/CA2543497C/en not_active Expired - Fee Related
- 2004-10-21 JP JP2006538094A patent/JP2007509937A/ja active Pending
- 2004-10-21 CN CNA2004800321539A patent/CN1874754A/zh active Pending
- 2004-10-21 RU RU2006118696/15A patent/RU2006118696A/ru not_active Application Discontinuation
- 2004-10-21 BR BRPI0415628-5A patent/BRPI0415628A/pt not_active IP Right Cessation
- 2004-10-21 KR KR1020067008415A patent/KR20060096492A/ko not_active Withdrawn
-
2006
- 2006-05-30 NO NO20062450A patent/NO20062450L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060096492A (ko) | 2006-09-11 |
| WO2005044230A2 (en) | 2005-05-19 |
| US20050095299A1 (en) | 2005-05-05 |
| EP1694297A2 (en) | 2006-08-30 |
| CA2543497A1 (en) | 2005-05-19 |
| CA2543497C (en) | 2013-02-26 |
| ES2408308T3 (es) | 2013-06-20 |
| WO2005044230A3 (en) | 2005-08-18 |
| EP1694297B1 (en) | 2013-04-10 |
| JP2007509937A (ja) | 2007-04-19 |
| BRPI0415628A (pt) | 2006-12-12 |
| RU2006118696A (ru) | 2007-12-10 |
| CN1874754A (zh) | 2006-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062450L (no) | Analgesiske suspensjoner med kontrollert frigivelse | |
| DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
| BR9810841A (pt) | Inibidores de metaloprotease alicìclicos | |
| WO2007078874A3 (en) | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors | |
| MY144659A (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
| NO20051008L (no) | Nye imidazolforbindelser som transformerende vekst faktor (TGF) inhibitorer | |
| NO20061506L (no) | Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav | |
| DK1694318T3 (da) | (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum | |
| BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| NO20050060L (no) | Medikament for behandling av overaktiv blaere | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| BR112021022255A2 (pt) | Composto usado como inibidor de quinase e aplicação do mesmo | |
| DE602007008385D1 (de) | Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris | |
| WO2003048122A3 (en) | Inhibitors of cytosolic phospholipase a2 | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| NO20080372L (no) | Pyrazolderivater som teraputiske midler | |
| EA200401319A1 (ru) | Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине | |
| NO20062442L (no) | Analgesiske suspensjoner md kontrollert frigivelse | |
| NO20054646L (no) | Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| UA89067C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ | |
| DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
| EA200500942A1 (ru) | Средство для лечения болезней суставов | |
| TNSN08531A1 (en) | Phenylacetic acid derivatives as cox - 2 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |